IVERMECTIN

Generic: IVERMECTIN

Advagen Pharma LtdManufacturer
ORALRoute
IVERMECTINActive Substance
2025-01-22Original Approval

IVERMECTIN is FDA application ANDA215922, sponsored by RUBICON RESEARCH. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Top Reported Reactions

1
OFF LABEL USE
387 reports
2
DRUG INEFFECTIVE
370 reports
3
PRODUCT USE IN UNAPPROVED INDICATION
255 reports
4
HEADACHE
162 reports
5
FATIGUE
123 reports
6
ASTHENIA
119 reports
7
NAUSEA
115 reports
8
PYREXIA
113 reports
9
STRONGYLOIDIASIS
102 reports
10
VOMITING
102 reports